Abstract
Background
Nigella sativa is the source of thymoquinone (TQ), an active phenolic compound with numerous pharmacological properties, including anti-tumor, anti-angiogenic, and antioxidant activities. Nevertheless, the mechanism by which TQ exerts its therapeutic effects and its potential utility in cancer treatment remain largely unknown.
Purpose
This study examine the potential anticancer properties of TQ at a concentrations of 8, 12, and 16 µg in colon cancer cells (HCT116).
Materials and Methods
We investigated the effects of TQ in promoting apoptosis and inhibiting cell proliferation in colon cancer cells (HCT116) in the present study. It showed that in TQ-treated HCT116 cells, antioxidant levels (superoxide dismutase, catalase and glutathione) were reduced in a dose-dependent manner (8, 12, and 16 µg), and that TQ significantly increased the production of reactive oxygen species, lipid peroxidation in terms of malondialdehyde, and loss of cell viability.
Results
Additionally, morphological changes and DNA fragmentation confirm that TQ induces oxidative stress-mediated apoptosis. Additionally, TQ treatment effectively increases the expression of Bax, caspase-9, and caspase-3 while decreasing the expression of Bcl-2 and Bcl-xl in colon cancer cells.
Conclusion
Our findings collectively demonstrate that TQ’s anti-tumor effects in HCT116 colon cancer cells reduce cell proliferation and promote apoptosis by modifying pro- and anti-apoptotic molecular events. Our results suggest that TQ could be utilized as a therapeutic agent to treat colon cancer.
Introduction
Colon cancer, also known as colorectal cancer, originates in the colon or rectum. According to the World Health Organization’s GLOBOCAN database, there were 1.8 million new cases and nearly 861,000 deaths worldwide in 2018, making it the third most common cancer in both men and women. 1
Unhealthy lifestyle choices, aging, smoking, obesity, poor diet, excessive alcohol use, and genetics can all contribute to colon cancer.2–4 Crohn’s disease and ulcerative colitis, both of which are components of inflammatory bowel disease, are additional risk factors. 5 A family history of colon cancer accounts for about 25% of cases, including 5% of cases brought on by the genetic syndromes of familial adenomatous polyposis or hereditary non-polyposis colorectal cancer. 6 It has been shown that 50% of patients with colon cancer experience cancer recurrence; this suggests that the current approaches to cancer treatment are ineffective. 7
An imbalance between the generation of free radicals, reactive metabolites, also known as oxidants or reactive oxygen species (ROS), and their removal by defense mechanisms known as antioxidants, is known as oxidative stress. Important biomolecules and cells are harmed by this imbalance, which may have an effect on the entire body. 8 In fact, increased DNA mutations or causes of DNA damage, genome instability, and cell proliferation have been connected to the development and spread of cancer. 9
One important mechanism for eliminating cancerous and pre-cancerous cells is apoptosis, which is also a valuable target for research on cancer drugs. 10 Apoptosis signaling in cancer cells is disrupted when the balance between pro- and anti-apoptotic factors is disrupted. It has been widely suggested that the basic mechanisms underlying apoptosis are overexpression of Bcl-2, downregulation of Bax, and decreased expression of caspases in a malignant environment. 11
Since many of the chemotherapeutic medications that are currently on the market have some side effects, many researchers are looking into plant-derived phytochemicals and assessing how well they work either by themselves or in conjunction with conventional chemotherapy to eradicate cancer cells and treat colon cancer. 12 The primary bioactive ingredient in Nigella sativa volatile oil is thymoquinone (TQ),13, 14 which functions as a potent antioxidant by scavenging dangerous free radicals, increasing natural antioxidant enzymes, and lowering inflammation. 15 TQ has been used against lung, liver, breast, and other neoplasms in vivo and in vitro with less cytotoxicity against normal cells due to its chemopreventive and anti-tumor properties.13, 16
Different studies have shown that TQ can target various mechanisms involved in cancer progression, including proliferation, 17 migration, 18 invasion/metastasis, 19 angiogenesis, and cancer stemness. 20
There are some reports available that show the beneficial effect of TQ in preventing colon cancer. In the present study, we conducted an in-depth evaluation of the relationship between oxidative stress and apoptosis through gene expression in the prevention of cancer proliferation.
Materials and Methods
Sigma-Aldrich (St. Louis, MO, USA) provided TQ (purity ≥98%). Applied Biosystems provided the RNA extraction kit; Macrogen Inc. (Seoul, Korea) designed all primers; and Bio-Rad (MA, USA) provided cDNA reverse transcription and SYBR Green. Every other chemical was of the highest purity grade or analytical quality.
Culture of Cells
King Abdulaziz University in Jeddah, Saudi Arabia, donated the HCT116 cell lines that they had acquired from ATCC. The obtained cells were cultivated in RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplemented with 1% streptomycin and penicillin antibiotics (Sigma-Aldrich, St. Louis, MO, USA) and 10% fetal bovine serum (Gibco, Paisley, UK). Every cell was maintained in a CO2 incubator at pH 7.4 and 37°C (New Brunswick, Scotland). In all the experiments, cells were seeded at 2 × 105 cells/mL and treated with TQ at 50%–60% confluence. All chemicals were dissolved in ethanol.
Cell Proliferation Assay
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test has been used to assess the effects of different doses of TQ to cause cell death. 21 In summary, 96-well culture plates were filled with 10,000 cells/mL of culture medium. The cells were cultivated for a full day in a CO2 incubator, which allowed them to multiply and adhere. The plates were removed from the incubator following the experiment’s first day, and new media with different concentrations of TQ were applied to the cells; the dose concentration varied from 1.56 to 100 µg/mL. The treated plates were then incubated for an additional 24 h. After the treatment was completed, 20 µL of MTT dye (5 mg/mL) (Invitrogen Corporation, San Diego, CA, USA) was added to each well and incubated for an additional 4 h. After the incubation period was over, the medium was carefully removed from the plates so as not to disturb the formazan crystals that had developed at the bottom of the plates. To facilitate the dissolution of the crystals, 100 µL of dimethyl sulfoxide (DMSO) (sourced from Fisher Chemicals in the UK) was then added to each well. The violet-hued final result at 570 nm was further examined using a microplate reader (BMG LABTECH, SpectroStar Nano, Ortenberg, Germany).
In order to find the cells’ vitality percentage, we used the raw data to calculate it from the relevant control values according to the method shown below. The experiments were repeated three times.
Cell Morphology
To view the morphological changes in the cultured cells, all of the treated and untreated cells in the flask (T25) were examined under an inverted microscope at 20× magnification after 24 h of TQ treatment.
Measurement of Reactive Oxygen Species Generation
Intracellular ROS generation was predicted using 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA). This non-fluorescent probe can freely infiltrate the intracellular matrix of cells, where it is oxidized by intracellular ROS to form the fluorescent DCF. Thus, fluorescence intensity is directly proportional to the quantity of ROS generated in the cells. 22 HCT116 cells were grown in a six‐well plate (3 × 104 per well) and treated with different concentrations of TQ (8, 12, and 16 µg) for 24 h.
Following a 24-h incubation period, 1 mL of cells was incubated for 10 min at 37°C with 100 mL of DCFH-DA. A Shimadzu RF-5301 PC spectrofluorimeter was used to measure the fluorescent intensity under a FLoid cell imaging station (Invitrogen) with excitation and emission filters set at 485 ± 10 and 530 ± 12.5 nm, respectively. The increasing percentage (%) of fluorescence intensity was used to express the results.
Biochemical Analysis
TQ (8, 12, and 16 µg) was added to the HCT116 cells. The cells were then collected and utilized for the biochemical analyses. The methods of Ohkawa et al., Kakkar et al., and Sinha23–25 were used to analyze the malondialdehyde (MDA) markers of lipid peroxidation (LPO), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) were estimated by Moron et al. 26
DNA Fragmentation
Researchers had previously described cells from which genomic DNA was extracted. 27 In summary, 1 × 106 cells were cultivated and exposed to 8, 12, and 16 µg of TQ. Trypsin was used to extract the treated cells, which were subsequently cleaned using Dulbecco’s phosphate-buffered saline (DPBS). Following the manufacturer’s instructions, the Qiagen DNA isolation kit was used to isolate DNA from the isolated cells. The nanodrop was used to measure the DNA concentration at 260 nm. Following that, 0.2% agarose gels containing 0.1 µg/mL ethidium bromide were used for DNA electrophoresis.
Gene Expression
The effect of TQ on mRNA expressions of Bcl-2, Bcl-xl, Bax, caspase-3, and caspase-9 was carried out by extracting mRNA from cells. mRNA was isolated by using the RNA extraction kit (BIO-RAD), and then cDNA was synthesized from the cDNA Reverse Transcription Kit (Applied Biosystems Cat# A25918). The cDNA templates were used to run the quantitative reverse transcription polymerase chain reaction (qRT-PCR) machine (Bio-Rad) by applying SYBR Green dye (Applied Biosystems). The sequences of the primers mentioned in Table 1 were obtained from Macrogen Inc. (Korea), and the reaction temperature and cycle duration were as per the manufacturer’s procedure. The β-actin expression is considered a reference standard. 28
List of Primer Sequences with Their Gene Accession Number.
Analysis of Statistics
The findings are presented as mean ± SD and were subjected to one-way analysis of variance (ANOVA) and post hoc analysis using Tukey’s techniques. A Student’s t-test without pairing was used to compare the two groups. A value of p < .05 is regarded as statistically significant.
Results
MTT Test
The MTT assay was used to determine the cytotoxic effect of TQ in HCT116 cells. The cells were exposed to varying concentrations of TQ (1.56, 3.125, 6.25, 12, 25, 50, and 100 µg/mL) for 24 h. The outcome demonstrated that TQ significantly and concentration-dependently inhibited cell proliferation. Thus, the growth inhibition curve (Figure 1) clearly shows that the inhibitory concentration (IC50) of TQ for HCT116 cells was 16 µg. Based on this outcome, we selected TQ concentrations of 8, 12, and 16 µg/mL for additional research.

Morphological Studies
There were significant differences between the treated and control cells. Treated cells showed several morphological changes that were visible at 20× magnification (Figures 2A–2D), in contrast to the untreated cells depicted in Figure 2A, which were observed 24 h after treatment. This provides a graphical depiction of these changes. More cells with traits like blebbing (purple arrow) of the cell membrane, greater growth inhibition, and cell lysis/shrinking (black arrow) were seen in cells treated with higher doses. Conversely, untreated cells persisted in adhering to one another throughout the whole incubation period.

Intracellular Reactive Oxygen Species
The measurement of intracellular ROS offers strong evidence that DCFH-DA dye caused oxidative stress in cancer cells (Figure 3). TQ concentrations of 8, 12, and 16 µg/mL were applied to HCT116 cells. As TQ dosage increases, ROS production is proportionately increased. In comparison to the control, at the 12 µg significance level (p < .01) and at the 16 µg level (p < .001).

Lipid Peroxidation and Antioxidant Status
One well-known biomarker for oxidative stress is elevated LPO and reduced antioxidant status. In comparison to the control, we found that HCT116 cells treated with TQ (8, 12, and 16 µg/mL) had higher levels of the LPO marker (MDA) dose dependently and lower levels of antioxidant enzymes (GSH, SOD, and CAT) with an increase in dose (Table 2). The results indicate significant changes in every parameter at 12 and 16 µg/mL (p < .01, p < .001).
Displaying Chemoprotective Effects of Thymoquinone (TQ) in HCT116.
DNA Fragmentation
Figure 4A displays the agarose gel electrophoretic pattern of the DNA degradation caused by TQ doses (lanes 16-8). The compact DNA (lane-C) of the control cell shows that the DNA of the cancerous cell is not fragmented, and is similar to low dosage (8 µg/mL). It was discovered that the ladder-like (smear-like) pattern of the DNA increased with the doses of TQ (lanes 16 and 12), corresponding to the 16 and 12 µg/mL, respectively, a common marker of apoptosis. Apoptosis can also be expressed as a percentage (%) of DNA degradation, with 100% as a control (Figure 4B). The study demonstrates that the DNA degradation of cancer cells increases from 124% to 288% with an increase in dose from 4 to 16 µg/mL, respectively (p < .05, p < .01, p < .001).

Real-time Quantitative Reverse Transcription Polymerase Chain Reaction
A change in the amplification of gene expression varies with an increase in the dose of TQ (Figure 5). Expression of anti-apoptotic markers like Bcl-2 and Bcl-xl is reduced with an increase in TQ doses (p < .01, p < .001). On the other hand, the pro-apoptotic markers such as Bax, caspase-3, and caspase-9 are increased with TQ. Our results are more significant at 12 and 16 µg/mL concentration (p < .01, p < .001), as compared to the control cell.

Discussion
Due to low toxicity, plant-derived phytosubstances, such as polyphenols, flavonoids, and phenolic agents, have attracted a lot of interest from the scientific community and the general public for the treatment of cancer. 30 These could be suitable for the treatment of cancer, along with the natural phytoingredients.
The three main therapeutic approaches used to treat colon cancer nowadays are radiation, chemotherapy, and surgery. Finding advanced therapies is a serious clinical challenge because of imperfect suppression of malignant cells and subsequent metastasis, despite improvements in cancer patient diagnosis and appropriate medical intervention. 31 Therefore, developing new chemotherapeutic medications is crucial. Phytonutrients derived from plants have drawn a lot of interest as a potential tactic to lower the incidence of tumor progression. 32 TQ treatment dramatically decreased the proliferation of HCT116 cells in our investigation. Numerous studies have shown that TQ has a non-toxic effect on normal cells and effectively suppresses cell growth in various cancer models.33, 34
In colon cancer, oxidative stress is essential for oxidative damage-mediated apoptosis. Severe oxidative damage to intracellular molecules results from an imbalance in the overproduction of ROS. 35 Plant-derived chemopreventive agents have been shown by numerous researchers to increase ROS generation, which may cause disruption of cancer cells redox homeostasis. 36 Early stages of apoptosis in cancer may be promoted by decreased intracellular antioxidant levels and increased lipid peroxidation levels due to the overproduction of dangerous free radicals. 37 Among the many promising and alluring biological effects of dietary phytochemicals is the anti-carcinogenesis effect. 38
Here, we observed elevated ROS production, indicating high fluorescence intensity in TQ-treated cells (Figure 3). Furthermore, oxidative DNA damage and other intracellular organelles can result in apoptotic cell death when intracellular ROS and transition metals are present. 39
According to a previous report, 40 the overproduction of ROS in TQ-treated HCT116 cell lines causes increased lipid peroxidation levels and consequently decreased antioxidant levels. 41 According to reports, TQ does not cause cytotoxicity in normal human intestinal FHs74Int cells, but it does inhibit proliferation and induce apoptosis in human colon cancer cells. 42
Another mechanism of cancer prevention is that TQ induces apoptosis, leading to increased expression of pro-apoptotic protein Bax, caspase-3, and caspase-9. At the same time, there is a decrease in the expression of anti-apoptotic proteins Bcl-2 and Bcl-xl. As a result, the changes in the pro-/anti-apoptotic ratio lead to favoring of cancer cells to undergo apoptosis. We also investigated that ROS induced oxidative stress-mediated apoptosis, by DNA fragmentation, and showed a higher percentage of DNA damage in TQ-treated cells.
Conclusion
Current findings demonstrate that TQ exhibits anti-tumor effects in HCT116 colon cancer cells by inhibiting proliferation and promoting apoptosis through pro- and anti-apoptotic molecular events. These observations suggest that TQ could be utilized as a therapeutic agent in modulating colon cancer. Further validation is required in multiple cell lines by in vivo studies and clinical investigations.
Also, future studies must include a comparison with standard chemotherapeutic agents to strengthen the manuscript to providing a clearer context for the therapeutic potential of TQ.
Footnotes
Abbreviations
Acknowledgments
The authors are highly thankful to Jazan University for financial support and the pharmacology lab for giving them space and the required chemicals to perform the present work.
Data Availability Statement
The authors confirm that the data supporting the findings of this study are available within the article.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical Approval
This study used established cell lines. No human participants, tissues, or animals were involved; therefore, ethical approval and informed consent were not required.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors gratefully acknowledge the funding of the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, through Project number: JU-202503277-DGSSR-RP-2025.
Informed Consent
The authors are highly thankful to laboratory at Pharmacy College and Jazan University for giving them space to perform the present work.
